- Home
- CC
as 10-07-2025 3:29pm EST
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 2.3B | IPO Year: | N/A |
| Target Price: | $18.13 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -2.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.13 - $22.38 | Next Earning Date: | 11-03-2025 |
| Revenue: | $5,850,000,000 | Revenue Growth: | 0.62% |
| Revenue Growth (this year): | 4.91% | Revenue Growth (next year): | 4.73% |
Stock Insider Trading Activity of Chemours Company (The) (CC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dignam Denise | CC | President & CEO | Aug 8 '25 | Buy | $12.06 | 4,068 | $49,060.08 | 191,546.155 |
Latest Chemours Company (The) News
CC Breaking Stock News: Dive into CC Ticker-Specific Updates for Smart Investing
Investing.com
6 days ago
Cocoa costs to ease but Berenberg cuts Mondelez, Barry Callebaut on weak demand
Insider Monkey
6 days ago
Chemours (CC) Price Target Lifted by Mizuho Amid Higher Market Multiples
Simply Wall St.
12 days ago
Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?
Insider Monkey
13 days ago
Jim Cramer on Chemours: “I Think it’s Chronically Undervalued”
ACCESS Newswire
a month ago
Delivering Trusted Chemistry: A Year of Progress and Purpose
Zacks
2 months ago
Chemours Enters Strategic Agreement With SRF to Boost Supply
Manufacturing Dive
2 months ago
Federal court orders Chemours to stop PFAS discharge from West Virginia facility
Zacks
3 months ago
CC Sees Gains From Opteon Growth in Q2, Navigates Disruptions in TT
Compare CC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CC Chemours Company (The) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.